We help your Medical Affairs department access qualitative and traceable RWE. At scale.
Tired of doubting your data's quality? Overwhelmed by the challenge of integrating disparate data sources? Are data governance and legal concerns slowing down your decision-making process?
Imagine having hassle-free access to robust and granular RWE you can trust.
At LynxCare, we free you to focus on what matters most – driving insights and advancing healthcare.
.png)
.png)
.svg)
How does the LynxCare Platform work?
LynxCare is a Belgian-US company that unlocks deep hospital RWE insights and enables life science organizations with strategic hospital RWE collaborations under a federated data governance model.
Our platform leverages AI & NLP to extract and harmonize (un)structured data from various hospital sources such as EHR, claims and lab data.
We are active in the EU for oncology, cardiology, rare diseases, and many more therapeutic areas.
Get inspired by some of our use cases.
- Unlocking Real-World Evidence about Immune Checkpoint Inhibitor Treatment in Diverse Cancer Types
- Real-World Eligibility for Dapagliflozin Treatment in Unselected Heart Failure Patients: Data from the Heart Failure Registry
- Detection of cardiac aTTR amyloidosis in a real-world heart failure population: automated data extraction from electronic health records using Natural Language Processing
- An Artificial Intelligence-driven framework to screen for hATTR polyneuropathy by automatically detecting red flag symptoms in Electronic Health Records
.png)
How our technology can facilitate more rapid diagnosis of rare diseases
Listen to Dries Hens M.D., Chief Medical Officer, and learn about a recent study performed by LynxCare and a Belgian hospital, in which a novel state-of-the-art NLP procedure was applied to automatically extract red flag symptoms from patients' EHRs and select patients at risk for ATTRv polyneuropathy, a rare disease, for further genetic testing.
Big data to gain further insights in a real-world heart failure population
Through analyzing data from both national registries and Electronic Health Records, further insights into the burden of heart failure on patients and on our healthcare systems can be gained.
Why life science organisations choose LynxCare
Unlock a previously untapped source of RWE
- Unlock the full potential of siloed and unstructured hospital data using AI & Natural Language Processing
Guaranteed data quality & traceability
- LynxCare provides data quality and data traceability guarantees. So HCPs and hospital researchers can rely on and check data quality at all times.
- The mined data is first validated by experts, and has an accuracy of >90%.
Secure collaborations under a federated model
- A federated AI data model ensures all data remains under the custody of the hospital or registry.
Benchmark across institutes and data sets
- Compare data sets across regions, institutes, languages and therapeutic areas.
Cost-efficient RWE insights
- Reduce time spent on validating data sets by deploying artificial intelligence to do the extraction.
Solidify your relations with healthcare organizations
- Use the value-add LynxCare provides to healthcare organizations to establish a long-term relationship.
Drive health innovation with RWE
Improving the quality of care through RWE collaborations.
Insights generated by RWE are only as qualitative as the data source.
We help you generate the RWE you need by making RWD actionable
Data governance matters.
Say goodbye to privacy concerns. Say hello to multi-center RWE studies.
We've got you covered.
Compliance excellence.
Privacy by design. Secure Infrastructure. Federated network.
.png)
.png)
Have a specific use case in mind? Talk to an expert.
Deployed over many therapeutic domains
Immuno-Oncology
Oncology
Cardiology
Rare diseases
Hematology
